Cargando…
Clinical Characteristics and Mortality in Patients With Cancer and COVID-19 From the Epicenter in New York City
PURPOSE/OBJECTIVE(S): The COVID-19 pandemic has resulted in over 2 million deaths worldwide and numerous studies demonstrate cancer patients are at increased risk of mortality. In this current study, the authors seek to investigate patient characteristics, clinical course, and predictors of COVID-19...
Autores principales: | Jones, B., Lehrer, E.J., Salgado, L. Resende, Shafaee, Z., Osborn, V.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536226/ http://dx.doi.org/10.1016/j.ijrobp.2021.07.1387 |
Ejemplares similares
-
Healthcare Disparities and Outcomes of Cancer Patients in a Community Setting from a COVID-19 Epicenter
por: Jones, Brianna M., et al.
Publicado: (2022) -
FRAILTY AND THE EFFECTIVENESS AND SAFETY OF NEW GLUCOSE-LOWERING DRUGS IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019) -
FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND SULFONYLUREA IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Pawar, Ajinkya, et al.
Publicado: (2019) -
FRAILTY AND THE COMPARATIVE EFFECTIVENESS AND SAFETY OF SGLT2I AND DPP4I IN OLDER ADULTS WITH TYPE 2 DIABETES
por: Kim, Dae H, et al.
Publicado: (2019) -
UTILIZATION TRENDS OF NEWLY APPROVED GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES
por: Dave, Chintan, et al.
Publicado: (2019)